WuXi Biologics (WXIBF)

Currency in USD
4.05
+0.04(+1.00%)
Closed·
WXIBF Scorecard
Full Analysis
Management has been aggressively buying back shares
Trading near 52-week High
Fair Value
Day's Range
4.054.05
52 wk Range
1.304.05
Key Statistics
Prev. Close
4.05
Open
4.05
Day's Range
4.05-4.05
52 wk Range
1.3-4.05
Volume
800
Average Volume (3m)
5.36K
1-Year Change
197.79%
Book Value / Share
1.4
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
WXIBF Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory

WuXi Biologics News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

WuXi Biologics Company Profile

WuXi Biologics (Cayman) Inc., an investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia. It operates through two segments: Biologics and XDC. The company provides a suite of solutions for biologic discovery, from concept to IND, that seamlessly transits to CMC and downstream process development through its contract research, development, and manufacturing organization platforms, including WuXiBody, SDArBodY, T cell engager, Single B Cell Cloning Technology, WuXia, WuXiUP, WuXiUI, and WuXiHigh. It engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, production and sales of medicals, and biologics clinical and manufacturing services; production and sale of medicals; vaccine contract development and manufacturing organization (CDMO) and related business; and engages in investment and material supplier activities. It has a research service agreement with BioNTech SE to discover and investigate monoclonal antibodies for developing next-generation therapeutic product candidates. The company was incorporated in 2014 and is headquartered in Wuxi, China.

Compare WXIBF to Peers and Sector

Metrics to compare
WXIBF
Peers
Sector
Relationship
P/E Ratio
37.2x−3.6x−0.5x
PEG Ratio
24.050.280.00
Price/Book
3.0x2.5x2.6x
Price / LTM Sales
6.7x4.4x3.2x
Upside (Analyst Target)
-46.4%42.0%
Fair Value Upside
Unlock−2.2%6.6%Unlock

Earnings

Latest Release
Apr 29, 2025
EPS / Forecast
0.44 / --
Revenue / Forecast
10.10B / --
EPS Revisions
Last 90 days

WXIBF Income Statement

People Also Watch

128.00
3690
-0.47%
118.00
9988
-2.24%
256.80
9992
-1.91%
122.20
1211
-4.75%

FAQ

What Stock Exchange Does WuXi Biologics Trade On?

WuXi Biologics is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for WuXi Biologics?

The stock symbol for WuXi Biologics is "WXIBF."

What Is the WuXi Biologics Market Cap?

As of today, WuXi Biologics market cap is 17.42B.

What Is WuXi Biologics's Earnings Per Share (TTM)?

The WuXi Biologics EPS (TTM) is 0.82.

From a Technical Analysis Perspective, Is WXIBF a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has WuXi Biologics Stock Split?

WuXi Biologics has split 0 times.

How Many Employees Does WuXi Biologics Have?

WuXi Biologics has 12575 employees.

What is the current trading status of WuXi Biologics (WXIBF)?

As of 30 Jul 2025, WuXi Biologics (WXIBF) is trading at a price of 4.05, with a previous close of 4.05. The stock has fluctuated within a day range of 4.05 to 4.05, while its 52-week range spans from 1.30 to 4.05.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.